Cargando…

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53

Detalles Bibliográficos
Autores principales:	Napoli, Marco, Girardini, Javier E., Piazza, Silvano, Del Sal, Giannino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2011
Materias:	Editorial Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248216/ https://www.ncbi.nlm.nih.gov/pubmed/21926448

Ejemplares similares

The rebel angel: mutant p53 as the driving oncogene in breast cancer
por: Walerych, Dawid, et al.
Publicado: (2012)

Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
por: Capaci, Valeria, et al.
Publicado: (2021)

Oncogenic Hijacking of the PIN1 Signaling Network
por: Zannini, Alessandro, et al.
Publicado: (2019)

Mutant p53 as a guardian of the cancer cell
por: Mantovani, Fiamma, et al.
Publicado: (2018)

Mutant p53: One, No One, and One Hundred Thousand
por: Walerych, Dawid, et al.
Publicado: (2015)

Dynamic regulation of Pin1 expression and function during zebrafish development
por: Ibarra, Maria Solange, et al.
Publicado: (2017)

Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo, Arianna, et al.
Publicado: (2018)

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
por: D'Artista, Luana, et al.
Publicado: (2016)

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
por: Lisek, Kamil, et al.
Publicado: (2018)

COVID-19: the vasculature unleashed
por: Teuwen, Laure-Anne, et al.
Publicado: (2020)

A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)

Effects of Pin1 Loss in Hdh(Q111) Knock-in Mice
por: Agostoni, Elena, et al.
Publicado: (2016)

Open questions: The disrupted circuitry of the cancer cell
por: Wiley, H Steven
Publicado: (2014)

Immunohistochemical Characterization of a Renal Nephroblastoma in a Trp53-mutant and Prolyl Isomerase 1-deficient Mouse
por: Castiglioni, Vittoria, et al.
Publicado: (2013)

Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
por: Rustighi, Alessandra, et al.
Publicado: (2014)

Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
por: Rustighi, Alessandra, et al.
Publicado: (2014)

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
por: Bisso, Andrea, et al.
Publicado: (2013)

The prolyl-isomerase Pin1 activates the mitochondrial death program of p53
por: Sorrentino, G, et al.
Publicado: (2013)

Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
por: Borini Etichetti, Carla M, et al.
Publicado: (2020)

Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
por: Tombari, Camilla, et al.
Publicado: (2023)

Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
por: Tombari, Camilla, et al.
Publicado: (2023)

The amplifier effect: how Pin1 empowers mutant p53
por: Hu, Hai, et al.
Publicado: (2011)

Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction
por: Antonelli, Roberta, et al.
Publicado: (2014)

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
por: Yao, David C., et al.
Publicado: (2014)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations
por: Restelli, Michela, et al.
Publicado: (2014)

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015)

Comparative Evaluation of the Efficacy of Combined Intramedullary Pinning with K-Wires Pinning in the Treatment of Fifth Metacarpal Neck Fractures versus Conventional Techniques—K-Wires Pinning and Intramedullary Pinning
por: Kim, Dong-Eun, et al.
Publicado: (2023)

Triggering p53 after cytokinesis failure
por: Stukenberg, P. Todd
Publicado: (2004)

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
por: Campaner, Elena, et al.
Publicado: (2017)

The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
por: Kadosh, Eliran, et al.
Publicado: (2020)

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness
por: Pegoraro, Silvia, et al.
Publicado: (2013)

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2021)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Role of Sex in the Therapeutic Targeting of p53 Circuitry
por: Mancini, Francesca, et al.
Publicado: (2021)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i2nmfdl71cl1lg1nsjpht8tu3u